Perceptive Advisors is a privately owned hedge fund sponsor that finances the public equity markets across the globe.
Perceptive Advisors, LLC is a privately owned hedge fund sponsor. The firm invests in the public equity markets across the globe. It employs a long/short equity strategy as a hedging technique while making its investments. The firm typically invests in biotechnology and life sciences sectors to make its investments. Perceptive Advisors is based in New York, New York.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 7, 2022
Apogee Therapeutics
|
Series B | $149M | Biotechnology | — |
Nov 16, 2022
Biodesix
|
Post-IPO Debt | $50M | Biotechnology | Yes |
Apr 12, 2022
Surf Bio
|
Seed | $16M | Biotechnology | Yes |
Mar 8, 2022
DNAnexus
|
Series H | $200M | Bioinformatics | — |
Dec 7, 2021
Freenome
|
Series D | $300M | Biotechnology | Yes |